Mann Brenda 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Nov 3, 2020
Insider Transaction Report
Form 4
Mann Brenda
VP of Research & Development
Transactions
- Tax Payment
Common Stock
2020-11-02$3.51/sh−96$337→ 17,462 total
Footnotes (1)
- [F1]Sale of shares to cover taxes due on restricted stock that vested on 11/01/2020.